Bhuvaneswari Ramaswamy

MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1

Tyler E. Miller, Kalpana Ghoshal, Bhuvaneswari Ramaswamy et al. · Journal of Biological Chemistry · 2008 · 741 citations · Full text

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Ultrasensitive Near‐Infrared Raman Reporters for SERS‐Based In Vivo Cancer Detection

Animesh Samanta, Kaustabh Kumar Maiti, K.L. Soh et al. · Angewandte Chemie International Edition · 2011 · 272 citations

Nanomedicine, Medicinal Chemistry, Engineering +15

Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway

Bhuvaneswari Ramaswamy, Yuanzhi Lu, Kun‐Yu Teng et al. · Cancer Research · 2012 · 189 citations · Full text

Hedgehog Signaling, Tamoxifen-resistant Breast Cancer, Tamoxifen Resistance +15

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102

Noah Kornblum, Fengmin Zhao, Judith Manola et al. · Journal of Clinical Oncology · 2018 · 184 citations · Full text

Breast Oncology, Estrogen Receptor, Gynecology +19